Back to calendar
Relmada Therapeutics, Inc. (RLMD) Earnings
RLMD reports earnings on Thursday, August 6, 2026
earnings report
August 6, 2026 · After Market Close
Q2 2026
Est. EPS: $-0.14
Actual EPS: $-0.11
EPS surprise: 44.87%
Company overview
Market Cap$506.1M
PriceUSD 4.75
EPS (TTM)-0.93
52-week high8.00
52-week low0.56
SectorHealth Technology
IndustryPharmaceuticals: Major
Employees17